The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genome sequencing can identify all noncoding variants, yet the discrimination of causal regulatory mutations represents a formidable challenge. We used epigenomic annotation in human embryonic stem cell (hESC)-derived pancreatic progenitor cells to guide the interpretation of whole-genome sequences from individuals with isolated pancreatic agenesis. This analysis uncovered six different recessive mutations in a previously uncharacterized ∼400-bp sequence located 25 kb downstream of PTF1A (encoding pancreas-specific transcription factor 1a) in ten families with pancreatic agenesis. We show that this region acts as a developmental enhancer of PTF1A ...
Cell type specification during pancreatic development is tightly controlled by a transcriptional and...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Individuals with permanent neonatal diabetes mellitus usually present within the first three months ...
The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genom...
Sequence variants in cis-acting enhancers are important for polygenic disease, but their role in Men...
This is the author accepted manuscript. The final version is available from the American Diabetes As...
The pancreas is a central organ for human diseases. Most alleles uncovered by genome-wide associatio...
Homozygous truncating mutations in the helix-loop-helix transcription factor PTF1A are a rare cause ...
GATA6 is a critical regulator of pancreas development, with heterozygous mutations in this transcrip...
We report a recurrent CNOT1 de novo missense mutation, GenBank: NM_016284.4; c.1603C>T (p.Arg535Cys)...
Genetic variants associated with type 2 diabetes (T2D) risk affect gene regulation in metabolically ...
GATA6 is a critical regulator of pancreatic development, with heterozygous mutations in this transcr...
Patients with pancreatic agenesis are born without a pancreas, causing permanent neonatal diabetes a...
Tissue-specific transcriptional regulation is central to human disease(1). To identify regulatory DN...
SummaryIdentifying cis-regulatory elements is important to understanding how human pancreatic islets...
Cell type specification during pancreatic development is tightly controlled by a transcriptional and...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Individuals with permanent neonatal diabetes mellitus usually present within the first three months ...
The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genom...
Sequence variants in cis-acting enhancers are important for polygenic disease, but their role in Men...
This is the author accepted manuscript. The final version is available from the American Diabetes As...
The pancreas is a central organ for human diseases. Most alleles uncovered by genome-wide associatio...
Homozygous truncating mutations in the helix-loop-helix transcription factor PTF1A are a rare cause ...
GATA6 is a critical regulator of pancreas development, with heterozygous mutations in this transcrip...
We report a recurrent CNOT1 de novo missense mutation, GenBank: NM_016284.4; c.1603C>T (p.Arg535Cys)...
Genetic variants associated with type 2 diabetes (T2D) risk affect gene regulation in metabolically ...
GATA6 is a critical regulator of pancreatic development, with heterozygous mutations in this transcr...
Patients with pancreatic agenesis are born without a pancreas, causing permanent neonatal diabetes a...
Tissue-specific transcriptional regulation is central to human disease(1). To identify regulatory DN...
SummaryIdentifying cis-regulatory elements is important to understanding how human pancreatic islets...
Cell type specification during pancreatic development is tightly controlled by a transcriptional and...
Diabetes mellitus is a metabolic disease characterised by relative or absolute pancreatic β cell dys...
Individuals with permanent neonatal diabetes mellitus usually present within the first three months ...